TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $285,000 | -42.9% | 15,000 | 0.0% | 0.18% | -45.9% |
| Q3 2021 | $499,000 | -14.3% | 15,000 | 0.0% | 0.34% | -2.3% |
| Q2 2021 | $582,000 | -19.5% | 15,000 | 0.0% | 0.35% | -18.9% |
| Q1 2021 | $723,000 | -7.3% | 15,000 | 0.0% | 0.43% | -4.5% |
| Q4 2020 | $780,000 | -2.7% | 15,000 | -50.0% | 0.45% | +67.5% |
| Q3 2020 | $802,000 | +174.7% | 30,000 | +100.0% | 0.27% | +52.3% |
| Q2 2020 | $292,000 | +97.3% | 15,000 | 0.0% | 0.18% | +34.4% |
| Q1 2020 | $148,000 | -11.4% | 15,000 | 0.0% | 0.13% | +8.3% |
| Q4 2019 | $167,000 | +98.8% | 15,000 | 0.0% | 0.12% | +116.1% |
| Q3 2019 | $84,000 | -35.4% | 15,000 | 0.0% | 0.06% | -29.1% |
| Q2 2019 | $130,000 | +7.4% | 15,000 | 0.0% | 0.08% | +3.9% |
| Q1 2019 | $121,000 | +95.2% | 15,000 | 0.0% | 0.08% | +28.8% |
| Q4 2018 | $62,000 | -26.2% | 15,000 | 0.0% | 0.06% | +9.3% |
| Q3 2018 | $84,000 | -57.4% | 15,000 | 0.0% | 0.05% | -59.7% |
| Q2 2018 | $197,000 | – | 15,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
| GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
| BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
| Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
| Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
| CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
| Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
| HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
| 683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
| Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |